Showing 1 - 20 results of 22 for search 'A. S. Ametov', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
The Role of Scintigraphy and Hybrid Single-Photon Emission Tomography in Comparison with Laboratory Data in a Comprehensive Examination of Patients with Secondary Hyperparathyroidi... by V. Е. Prokina, А. А. Ansheles, A. V. Tarasov, A. S. Ametov, V. B. Sergienko
Published 2022-07-01Get full text
Article -
8
The Scientific Advisory board resolution: Implementation of intermittently scanned Continuous Glucose monitoring in clinical practice to improve glycemic control by V. A. Peterkova, A. S. Ametov, A. Y. Mayorov, G. R. Galstyan, D. N. Laptev, N. A. Chernikova
Published 2021-07-01Get full text
Article -
9
-
10
Comparative analysis of pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of semaglutide-based drug for the treatment of obesity by A. S. Ametov, P. A. Bely, K. Y. Zaslavskaya, E. A. Rogozhina, V. S. Shcherbakova, Y. G. Kazaishvili, A. V. Taganov, T. G. Bodrova, E. S. Mishchenko, K. N. Koryanova, L. I. Shcherbakova
Published 2025-03-01Get full text
Article -
11
Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide by A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, S. M. Noskov
Published 2023-11-01Get full text
Article -
12
-
13
EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DIS... by A. Catapano, E. V. Shlyakhto, A. I. Martynov, R. G. Oganov, V. V. Kukharchuk, M. V. Shestakova, A. S. Ametov, S. A. Boicov, M. G. Bubnova, S. V. Villevalde, A. S. Galyavich, Yu. A. Karpov, J. D. Kobalava, O. N. Koziolova
Published 2013-08-01Get full text
Article -
14
Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board by M. V. Shestakova, V. A. Dobronravov, A. S. Ametov, M. B. Antsiferov, M. M. Batyushin, I. N. Bobkova, G. R. Galstyan, T. Y. Demidova, V. V. Klimontov, A. M. Mkrtumyan, N. A. Petunina, E. I. Prokopenko, N. V. Chebotareva, M. S. Shamkhalova
Published 2023-11-01Get full text
Article -
15
Resolution on the results of the First All-Russian Forum "Therapeutic Education in Endocrinology" by M. V. Shestakova, A. Yu. Mayorov, E. V. Surkova, G. R. Galstyan, A. S. Ametov, M. B. Antsiferov, E. G. Starostina, O. G. Melnikova, L. I. Ibragimova, E. A. Andrianova, E. V. Ershova, I. A. Karpova, I. V. Kononenko, A. V. Tiselko, V. K. Fedyaeva
Published 2022-07-01Get full text
Article -
16
Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice by N. G. Mokrysheva, M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, I. G. Bakulin, T. V. Vavilova, G. R. Galstyan, T. Y. Demidova, F. K. Dzgoeva, T. L. Karonova, E. A. Lukina, A. M. Mkrtumyan, N. A. Petunina, R. V. Ponomaryov, N. A. Suponeva, O. Y. Sukhareva, M. S. Shamkhalova
Published 2024-07-01Get full text
Article -
17
Erratum: Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice (Diabetes mellitus. 2024;27(3). doi: 10.14341/DM13181) by N. G. Mokrysheva, M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, I. G. Bakulin, T. V. Vavilova, G. R. Galstyan, T. Y. Demidova, F. K. Dzgoeva, T. L. Karonova, E. А. Lukina, A. M. Mkrtumyan, N. А. Petunina, R. V. Ponomaryov, N. A. Suponeva, O. Y. Sukhareva, M. S. Shamkhalova
Published 2024-09-01Get full text
Article -
18
Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board by M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, T. P. Bardymova, F. V. Valeeva, G. R. Galstyan, T. Yu. Demidova, I. A. Karpova, T. P. Kiseleva, A. Yu. Mayorov, A. M. Mkrtumyan, S. V. Nedogoda, N. А. Petunina, L. A. Ruyatkina, L. A. Suplotova, O. Yu. Sukhareva, V. V. Fadeev, M. S. Shamkhalova
Published 2022-01-01Get full text
Article -
19
Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide by A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, V. S. Scherbakova, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, E. Yu. Kesova, E. D. Kozlov, E. S. Samoshkina, D. N. Andreev, Yu. G. Kazaishvili, S. M. Noskov, L. A. Balykova
Published 2024-01-01Get full text
Article -
20
Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial by Yu. M. Lopatin, G. P. Arutyunov, A. S. Ametov, F. T. Ageev, M. B. Antsiferov, O. L. Barbarash, S. V. Villevalde, N. G. Vinogradova, G. R. Galstyan, A. S. Galyavich, S. R. Gilyarevsky, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, A. Yu. Lebedeva, S. V. Nedogoda, V. V. Salukhov, E. I. Tarlovskaya, S. N. Tereshchenko, I. V. Fomin, Yu. Sh. Khalimov, D. V. Cherkashin
Published 2022-04-01Get full text
Article